Clinical Trial Update: Registry Platform Gastric/Esophageal Cancer (SAPHIR)

View source ↗

Summary

This Clinical Trial Update reports an ongoing registry platform trial SAPHIR addressing gastric and esophageal cancers, currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophageal Squamous Cell Carcinoma
• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: iOMEDICO AG | Conditions: Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma | Status: RECRUITING